|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 ) P* i0 y5 B! T0 l/ w/ E5 C
6 F5 n- F7 m6 t6 K: c, O5 {5 s今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了+ ^. B/ u$ A; G1 h k X+ e
+ e0 O' v, _7 o# L/ K头颈肿瘤BU入选ASCO 2025的研究) Z+ w3 g: \% w
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.$ ?# U; n/ S- v# V! Y5 h
肿瘤内科-头颈肿瘤科姜愚团队
- M8 \' D* O7 S* o" v, P# o& ~8 B5 G: i% s
Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
. t5 ^, C- d( \' H; B肿瘤内科-头颈肿瘤科刘磊团队9 E: f: A3 L3 l% W& q ^! l
" z/ x2 [( e+ F: V1 z* s! EA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
6 i# o5 D) \9 ~' _1 v( i& v肿瘤内科-头颈肿瘤科刘磊团队
" e& F4 w d7 ~4 D% f7 @# M" ~# c3 X
' r% v+ R# A Z5 v' S+ j6 g3 nA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
+ k: ^5 ]) l3 W1 c: ~) a/ _肿瘤内科-头颈肿瘤科刘磊团队
- I* F5 a- z' ~# T, Y$ r8 }$ |" C, s. [" H2 Z) c/ ^4 d- J
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.2 s2 V% l' R- M) u% d
肿瘤内科-头颈肿瘤科姜愚团队6 }5 Q0 d3 T( G( Z
|
|
[复制链接]
发表于 2025-5-2 09:58:22
_# J+ l) P0 o* ?* n